MTOR and neoplasm: Additionally, mTORC2/AKT signaling activates proliferative cell cycles in cancer cells, leading to tumor development, through the binding of mutated rat sarcoma virus (RAS) proteins to mTOR components of mTORC2 and mitogen-activated protein kinase-associated protein 1 (MAPKAP1) [51].